Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,726,746 papers from all fields of science
Search
Sign In
Create Free Account
Oxymorphone Hydrochloride
Known as:
4,5-alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one Hydrochloride
, Oxymorphone HCl
, Oxymorphone Hydrochloride [Chemical/Ingredient]
The hydrochloride salt form of oxymorphone, a semisynthetic opioid with a potent analgesic property. Oxymorphone hydrochloride binds to and activates…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
1 ML Oxymorphone Hydrochloride 1 MG/ML Injection [Opana]
12 HR Oxymorphone Hydrochloride 10 MG Extended Release Oral Tablet [Opana]
12 HR Oxymorphone Hydrochloride 30 MG Extended Release Oral Tablet
Drug Allergy
Expand
Narrower (2)
Numorphan
Opana
Broader (1)
Oxymorphone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Untangling the web of opioid addictions in the USA
T. Lancet
The Lancet
2017
Corpus ID: 195669604
Review
2016
Review
2016
(443) Evaluation of the clinical abuse potential of Opana ER versus oxymorphone HCl powder.
N. Shusterman
,
F. Diana
,
+4 authors
B. Vince
Journal of Pain
2016
Corpus ID: 20983086
2015
2015
A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With…
J. Markman
,
J. Gewandter
,
+8 authors
R. Dworkin
Spine
2015
Corpus ID: 38333789
Study Design. Randomized, double-blind, placebo-controlled, single-dose crossover study. Objective. To test the analgesic…
Expand
2014
2014
Chronic pain, addiction, and Zohydro.
Y. Olsen
,
J. Sharfstein
New England Journal of Medicine
2014
Corpus ID: 205110432
Twenty-nine state attorneys general have asked the FDA to reconsider its approval of the opioid Zohydro, which lacks abuse…
Expand
2014
2014
Use of prescription opioids with abuse-deterrent technology to address opioid abuse
E. Michna
,
N. Kirson
,
A. Shei
,
H. Birnbaum
,
R. Ben-Joseph
Current Medical Research and Opinion
2014
Corpus ID: 25332857
Abstract Objective: The development of new formulations of extended-release (ER) opioids with abuse-deterrent technology attempts…
Expand
Highly Cited
2012
Highly Cited
2012
Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.
S. Vosburg
,
Jermaine D. Jones
,
J. Manubay
,
J. Ashworth
,
I. Benedek
,
S. Comer
Drug and Alcohol Dependence
2012
Corpus ID: 1622020
Review
2008
Review
2008
Oxymorphone: a mature molecule with new life.
J. Gimbel
Drugs of Today
2008
Corpus ID: 703566
The undertreatment of acute and chronic pain continues to be a significant health concern in the U.S. Opioids are recommended for…
Expand
2007
2007
Oxymorphone hydrochloride, a potent opioid analgesic, is not carcinogenic in rats or mice.
D. Shuey
,
C. Woodland
,
C. Tremblay
,
R. Gregson
,
R. J. Gerson
Toxicological Sciences
2007
Corpus ID: 21174520
Despite their long history of chronic use, little information is available regarding the carcinogenicity of opioid analgesics…
Expand
2003
2003
Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of postsurgical visceral pain in rats.
L. Krugner-Higby
,
Lesley J Smith
,
+6 authors
A. Wendland
Comparative medicine
2003
Corpus ID: 35577294
Adequate pain control is necessary for optimal postsurgical recovery and humane treatment of laboratory and companion animals…
Expand
2000
2000
Modulation of adenosine concentration by opioid receptor agonists in rat striatum.
G. Halimi
,
C. Devaux
,
+4 authors
R. Guieu
European Journal of Pharmacology
2000
Corpus ID: 30784239
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE